Company intelligence / Profile preview

CrestOptics

Ownership: Private
Employees: ~59
Development stage: Commercial

Overview

CrestOptics develops and manufactures advanced fluorescence microscopy systems—including super-resolution and spinning disk confocal modules—used worldwide for biological research, diagnostics, and industrial applications. Their technologies enable high-end fluorescence imaging for the life sciences sector. The company has a strong R&D focus with over 25% of turnover invested annually in innovation. No clinical trial results as they do not develop therapeutics.

Industry: Pathology

Partnerships

Crisel Instruments partnership for live cell imaging market knowledge in Italy

Beyond the preview

Go deeper on CrestOptics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CrestOptics.

Explore the full profile